• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vet Rec . Validation of a reduction in time for avian influenza virus isolation using specific pathogen-free embryonated chicken eggs

tetano

Editor, Senior Moderator
Vet Rec


. 2024 Nov 19:e4842.
doi: 10.1002/vetr.4842. Online ahead of print. Validation of a reduction in time for avian influenza virus isolation using specific pathogen-free embryonated chicken eggs

Scott M Reid[SUP] 1 [/SUP], Vivien J Coward[SUP] 1 [/SUP], Joe James[SUP] 1 2 [/SUP], Rowena D E Hansen[SUP] 1 [/SUP], Colin Birch[SUP] 3 [/SUP], Mayur Bakrania[SUP] 3 [/SUP], Sharon M Brookes[SUP] 1 [/SUP], Ian H Brown[SUP] 1 2 [/SUP], Ashley C Banyard[SUP] 1 2 [/SUP]



Affiliations
Abstract

Background: The international gold standard for avian influenza virus (AIV) diagnosis is virus isolation (VI) in specific pathogen-free embryonated chicken eggs (ECEs). AIV isolation typically involves a 6-day turnaround, during which premises under suspicion for notifiable AIV infection are held under restriction regardless of molecular diagnoses, often with significant welfare implications.
Methods: A reduction in time for negation by VI was investigated following experimental inoculation of AIV from known-positive original clinical material into ECEs. VI data derived from more than 600 case investigations from epizootics of high-pathogenicity AIV (HPAIV) in Great Britain since 2016 and from low-pathogenicity AIV (LPAIV) cases in Great Britain since 2014 were examined to support a reduction in test timing using alternative regimens.
Results: HPAIVs were isolated during the first passage, and for LPAIV VI, the second passage could be reduced to 2 days. Power analysis showed that the benefit of reducing the number of days outweighed the risk of missing a positive isolate.
Limitations: Limited data were available from experimental inoculations.
Conclusion: This truncated methodology, which enables an earlier release of restrictions, may substantially ease the economic implications of restriction. It could also reduce bird welfare implications and improve international standards without loss of test performance.

Keywords: avian influenza virus; embryonated chicken eggs; notifiable avian disease; virus isolation.

 
Back
Top Bottom